Expression of basic fibroblast growth factor is associated with a good outcome in patients with squamous cell carcinoma of the esophagus

Oncology Reports

Volumn 14, Issue 3, 2005, Pages 617-623

  Nakamura, Takeshi ^a   Ozawa, Soji ^a   Kitagawa, Yuko ^a   Shih, Chih Horng ^a   Ueda, Masakazu ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor; Platelet derived endothelial cell growth factor; Prognosis; Squamous cell carcinoma

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; TREATMENT OUTCOME;

EID: 24644447915     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.3.617     Document Type: Article

References (38)

1. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82: 4-6, 1990.
2. Shih CH, Ozawa S, Ando N, Ueda M and Kitajima M: Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clinical Cancer Res 6: 1161-1168, 2000. (Pubitemid 30159380)
3. Montesano R, Vassalli JD, Baird A, Guillemin R and Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297-7301, 1986. (Pubitemid 16000508)
4. Slavin J: Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 19: 431-444, 1995.
5. Janot F, El-Naggar AK, Morrison RS, Liu TJ, Taylor DL and Clayman GL: Expresson of basic fibrobrast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 64: 117-123, 1995.
6. Takanami I, Imamura T, Haseizume T, Kikuchi K, Yamamoto Y, Yamamoto T and Kodaira S: Immunohistochemical detection of basic faibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma. Jpn J Clin Oncol 26: 293-297, 1996. (Pubitemid 126470686)
7. Blanckaert VD, Hebber M, Louchez M-M, Vilain M-O, Schelling ME and Peyrat JP: Basic fibroblast growth factor receptors and their prognostic value in human breast cancer. Clin Cancer Res 4: 2939-2947, 1998. (Pubitemid 29001465)
8. Miyazono K, Okabe T, Urabe A, Takaku F and Heldin CH: Purification and properties of an endothelial-cell growth factor from human platelets. J Biol Chem 262: 4098-4103, 1987. (Pubitemid 17102635)
9. Ishikawa F, Miyazono K, Hellman U, Draexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989. (Pubitemid 19102308)
10. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishuzawa M, Yamada Y and Akiyama S: Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem 114: 9-14, 1993. (Pubitemid 23235624)
11. Takebayashi Y, Miyadera K, Akiyama SI, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T: Expression of thymidine phosphorylase in human gastric cancer. Jpn J Cancer Res 87: 288-295, 1996. (Pubitemid 26117060)
12. Maeda K, Kang SM, Ogawa M, Onoda N, Sawada T, Nakata B, Kato Y, Chung YS and Sowa M: Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer 74: 545-550, 1997. (Pubitemid 27486514)
13. Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S and Chayama K: Expression of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 26: 344-349, 2003. (Pubitemid 36529959)
14. Kaio E, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haruma K and Chayama K: Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 64: 61-73, 2003. (Pubitemid 35477956)
15. Kitadai Y, Onogawa S, Kuwai T, Matsumura S, Hamada H, Ito M, Tanaka S, Yoshihara M and Chayama K: Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep 11: 315-319, 2004.
16. Oka K, Suzuki Y, Iida H and Nakano T: PD-ECGF positivity correlates with better survival, while iNOS has no predictive value for cervical carcinomas treated with radiotherapy. Int J Radiat Oncol Biol Phys 57: 217-221, 2003. (Pubitemid 36959759)
17. Japanese Society for Esophageal Disease: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 9th edition. Kanehara Co. Ltd., Tokyo, 1999.
18. Li Z, Shimada Y, Uchida S, Maeda M, Kawabe A, Mori A, Itami A, Kano M, Watanabe G and Imamura M: TGF-α as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int J Oncol 17: 453-460, 2000.
19. Ohta T, Yamamoto M, Numata M, Iseki S, Tsukioka Y, Miyashita T, Kayahara M, Nagakawa T, Miyazaki I, Nishikawa K and Yoshitake Y: Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas. Br J Cancer 72: 824-831, 1995.
20. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O and Nagasue N: The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 82: 1225-1232, 1998. (Pubitemid 28155382)
21. Koide N, Watanabe H, Yazawa K, Adachi W and Amano J: Immunohistochemical expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus. Hepatogastroenterology 46: 944-951, 1999. (Pubitemid 29224770)
22. Gospodarwicz D, Neufeld G and Schweigerer L: Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm- and neuroectoderm-derived cells. Cell Diff 19: 1-17, 1986. (Pubitemid 16036421)
23. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC and Gospodarowicz D: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325: 257-259, 1987. (Pubitemid 17049885)
24. Denekamp J: Inadequate vasculature in solid tumors: consequences for cancer research strategies. Br J Radiol 24: 111-117, 1992.
25. Folkman J and Klagsburn M: Angiogenic factors. Science 235: 442-447, 1987. (Pubitemid 17009577)
26. Rizzino A, Ruff E and Rizzino H: Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-B. Cancer Res 46: 2816-2820, 1986. (Pubitemid 16074287)
27. Ristow HJ and Messmer TO: Basic fibroblast growth factor an insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 137: 277-284, 1988.
28. Tanimoto H, Yoshida K, Yokozaki H, Yasui W, Nakayama H, Ito H, Ohma K and Tahara E: Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch B Cell Pathol 61: 263-267, 1991.
29. Becker D, Meier CB and Herlyn M: Proliferation of human malignant melanomas is inhibited by anti-sense oligodeoxy-nucleotides targeted against basic fibroblast growth factor. EMBO J 8: 3685-3691, 1989 (Pubitemid 20016047)
30. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kukuchi H and Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular sources of basic fibroblast growth factor mRNA and peptide in tumor tissue. Proc Natl Acad Sci 87: 5710-5715, 1990.
31. Zagzag D, Miller DC, Sato Y, Rifkin DB and Burstein DE: Immunohistochemial localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393-7398, 1990.
32. Eguchi J, Nomata K, Kanda S, Igawa T, Taide M, Koga S, Matshuya F, Kanetani H and Saito Y: Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma. Biochem Biophys Res Commun 183: 937-944, 1992.
33. Obermair A, Speiser P, Reisenberger K, Ullrich R, Czerwenka K, Kaider A, Zeillinger R and Miksche M: Influence of intramural basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett 130: 69-76, 1998. (Pubitemid 28425339)
34. Brattstrom D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Reosenberg L, Brodin O and Wagenius G: Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res 18: 1123-1128, 1998.
35. Colomer R, Aparicio J, Montero S, Guzman C, Larrodera L and Cortes-Funes H: Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br J Cancer 76: 1215-1220, 1997. (Pubitemid 27448020)
36. Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani YA, Shousha S, Coombes RC and Johnston CL: Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer 75: 28-33, 1997. (Pubitemid 27007269)
37. Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J and Harris AL: Up-regulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival. Ann Oncol 10: 707-713, 1999. (Pubitemid 29355089)
38. Korah RM, Sysounthone V, Golowa Y and Wieder R: Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res 60: 733-740, 2000. (Pubitemid 30094575)